Trends in atopic dermatitis prevalence among the Chinese population (1990–2021) with projections for 2022–2030

医学 特应性皮炎 人口学 人口 流行 队列 年龄组 疾病负担 儿科 内科学 环境卫生 皮肤病科 社会学
作者
Jingjing Zhou,Huijing Chen,Shangcheng Zhou,Ailing Liu,Shanshan Liang,Xiaoning Sun,Kaiyue He
出处
期刊:Pediatric Allergy and Immunology [Wiley]
卷期号:35 (10): e14271-e14271 被引量:7
标识
DOI:10.1111/pai.14271
摘要

Abstract Background Atopic dermatitis (AD) has the highest disease burden among all skin diseases. However, reports on AD prevalence trends in China are limited. This study aimed to investigate the time trends of AD prevalence in China from 1990 to 2021 and to explore the age and sex differences. Methods Data were obtained from the Global Burden of Disease Study, 2021. We analyzed the annual percentage change in the crude prevalence rate and age‐standardized prevalence rate (ASPR) of AD from 1990 to 2021 using the Joinpoint model. We predicted the future prevalence of AD from 2022 to 2030 using the Bayesian age–period–cohort model. Results The total ASPR decreased slightly from 1990 (1357.93 per 100,000) to 2021 (1347.11 per 100,000). The ASPR of females (1457.64 per 100,000) was higher than that of males (1247.04 per 100,000) in 2021. The prevalence rate of AD was highest in the under 5 years old age group (3455.56 per 100,000) and the 5–9 years old age group (3360.31 per 100,000). By 2030, the predicted ASPR of AD will be 1394.36 (per 100,000) in males and 1603.69 in females (per 100,000). The predicted prevalence rate in the under 5 years old (3996.14 per 100,000 in males and 3990.68 per 100,000 in females) and 5–9 years old (3714.61 per 100,000 in males and 3963.96 per 100,000 in females) age groups will be higher than those in other age groups. Conclusion Despite a slight decrease from 1990 to 2021, there has been an increasing trend since 2015 in the total AD burden. Given the increasing burden of AD on Chinese children and females, healthcare practitioners should enhance community education, improve disease management abilities of patients and caregivers, and reduce the burden and healthcare costs of AD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小怡子完成签到,获得积分10
刚刚
刚刚
纳兰嫣然完成签到,获得积分10
1秒前
1秒前
缓慢的棒棒糖完成签到,获得积分20
1秒前
高高行云完成签到 ,获得积分10
2秒前
2秒前
2秒前
3秒前
TTT发布了新的文献求助10
3秒前
科研通AI6应助utd24accepted采纳,获得50
3秒前
3秒前
活力顿阿雪完成签到,获得积分10
3秒前
4秒前
尤里有气完成签到,获得积分10
4秒前
4秒前
cox完成签到 ,获得积分10
5秒前
cc2941完成签到,获得积分10
5秒前
5秒前
无力完成签到,获得积分10
5秒前
5秒前
5秒前
6秒前
dingding发布了新的文献求助30
6秒前
6秒前
桐桐应助un采纳,获得10
7秒前
前进的尔槐完成签到,获得积分10
7秒前
panghu233发布了新的文献求助10
7秒前
8秒前
研友_VZG7GZ应助Natural采纳,获得10
9秒前
fwz发布了新的文献求助10
9秒前
9秒前
9秒前
月子淇应助眼睛大的老虎采纳,获得10
9秒前
隐形曼青应助momo采纳,获得10
10秒前
10秒前
会飞的喵发布了新的文献求助30
10秒前
无力发布了新的文献求助10
10秒前
不安青牛发布了新的文献求助10
10秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Iron toxicity and hematopoietic cell transplantation: do we understand why iron affects transplant outcome? 2000
List of 1,091 Public Pension Profiles by Region 1021
Teacher Wellbeing: Noticing, Nurturing, Sustaining, and Flourishing in Schools 800
Efficacy of sirolimus in Klippel-Trenaunay syndrome 500
上海破产法庭破产实务案例精选(2019-2024) 500
EEG in Childhood Epilepsy: Initial Presentation & Long-Term Follow-Up 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5477903
求助须知:如何正确求助?哪些是违规求助? 4579712
关于积分的说明 14370069
捐赠科研通 4507919
什么是DOI,文献DOI怎么找? 2470291
邀请新用户注册赠送积分活动 1457179
关于科研通互助平台的介绍 1431135